BioSpace News Archive

Awards from Press Ganey highlight care provided by the Center for Fetal Diagnosis and Treatment and its Garbose Family Special Delivery Unit

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic – to be used with investigational cancer treatment BNT113 – which identifies patients with squamous cell carcinoma of the head and neck (SCCHN) that are caused by specific infections by human papilloma virus (HPV).

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for DEFINITY® Room Temperature

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its shareholders have elected Andrea M. Walsh to serve as an additional director of the Company.

STERIS plc announced that is has completed the previously announced acquisition of Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC.

AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, today announced it has acquired Trianni, Inc. in an all-cash transaction valued at US$90 million.

British Virgin Island headquartered Lytus Technologies Holdings Private Limited (Lytus), a technology-platforms company that offers streaming and telemedicine services with business operations in the United States and India, has signed a strategic business cooperation agreement with Singapore based True Healthcare Pte Limited (True Health).

Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences.

AbbVie Inc. (NYSE:ABBV) (“AbbVie”) announced today the expiration and final results of its offers to exchange (the “Registered Exchange Offers”) any and all of its outstanding (i) $30,000,000,000 aggregate principal amount of senior unsecured notes previously issued on November 21, 2019 (the “2019 USD Notes”), (ii) $13,251,781,000 aggregate principal amount of senior unsecured notes previously issued on May 14, 2020

Immutep Limited (ASX: IMM; NASDAQ: IMMP) : Australian biotechnology company Immutep Limited (“Immutep“ or the “Company“), which is listed on NASDAQ and the Australian Securities Exchange, is pleased to announce that it has today successfully completed a A$29.6 million a private placement of ordinary shares to professional and institutional investors (Placement).